NCT02228005View on ClinicalTrials.gov

The Effect of a Selective Serotonin Reuptake Inhibitor on Gait, Balance, and Bone Metabolism in Older Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Depression
Interventions
DRUG

Sertraline

Protocolized titration from 50 to max 200mg based on response and tolerance.

Trial Locations (1)

M5G2A2

Toronto Rehabilitation Institute, University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02228005 - The Effect of a Selective Serotonin Reuptake Inhibitor on Gait, Balance, and Bone Metabolism in Older Adults | Biotech Hunter | Biotech Hunter